ALMIRALL ALMIRALL S.A./ ES0157097017 /
2024-04-23 5:35:01 PM | Chg. +0.1200 | Volume | Bid6:02:17 PM | Ask6:02:17 PM | High | Low |
---|---|---|---|---|---|---|
8.3600EUR | +1.46% | 131,086 Turnover: 1.09 mill. |
8.1500Bid Size: 50 | 8.3800Ask Size: 948 | 8.3800 | 8.2600 |
GlobeNewswire
2023-11-14
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for de...
GlobeNewswire
2021-09-27
Athenex Announces Phased European Launch of Klisyri® (tirbanibulin) for the Treatment of Actinic Ker...
GlobeNewswire
2021-07-19
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment ...